Recent insider trading activity from Neuman Linda L, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2023 | Spyre Therapeutics, Inc. | $SYRE | Neuman Linda L | Chief Medical Officer | A | Employee Stock Option (right to buy) | 550000 | $0.00 | 550,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2022 | Spyre Therapeutics, Inc. | $SYRE | Neuman Linda L | Chief Medical Officer | A | Employee Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |